How Genetic Risk and Inflammation Disrupt Beta Cell Function in Type 1 Diabetes

Type 1 diabetes develops when the immune system mistakenly attacks the insulin-producing beta cells in the pancreas. But genetics alone don't tell the whole story. Researchers have long known that both genetic susceptibility and problems with how genes are turned on and off—a process called epigenetic regulation—play important roles in disease risk.

What has remained unclear is how these genetic risk factors directly affect beta cell function. A new study published on bioRxiv tackled this question by examining the connection between disease-associated genetic variants and the control systems that govern beta cell gene expression.

The research team focused on enhancers—stretches of DNA that act like dimmer switches for genes, controlling when and how actively they are expressed. They combined multiple types of genetic and molecular data from human pancreatic islets to map which enhancers are active specifically in beta cells.

Using publicly available epigenomic datasets and single-cell analysis techniques, the scientists identified disease-associated genetic variants that are located within these beta cell enhancers. This is significant because when a genetic variant sits in an enhancer region, it can potentially disrupt the binding of transcription factors—proteins that turn genes on and off—and alter how much gene product is made.

To predict which variants might actually harm beta cell function, the researchers applied advanced computational methods, including a deep learning model called ChromBPNet. This tool analyzes how specific genetic changes might alter the accessibility of DNA to regulatory proteins, essentially showing which variants could disrupt the molecular machinery that controls gene expression.

The team also used a technique called transcription factor footprinting to identify which regulatory proteins are likely affected by these variants. By combining computational predictions with analysis of actual beta cells from people with and without Type 1 diabetes, they built a clearer picture of how genetic risk factors may damage beta cell function at the molecular level.

These findings help explain an important observation: beta cells show signs of dysfunction before Type 1 diabetes is diagnosed. This suggests that problems within the beta cells themselves—not just immune attack—are part of how the disease develops.

By identifying the specific genetic variants and regulatory regions involved in beta cell dysfunction, this research provides a foundation for future work. Understanding these mechanisms could eventually help researchers identify people at highest risk of developing Type 1 diabetes and could guide the development of new strategies to prevent or delay disease onset.

Source: bioRxiv : the preprint server for biology. Evidence type: PubMed indexed literature. Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.